Section 2: Antimicrobial Stewardship in Everyday Practice (Self Study for medical students)
Content in this section is available through 5 case-based eLearning scenarios. These include:
- AS in Everyday Practice: A Clinic Visit Case
- AS in Everyday Practice: The Antibiotic Approval Request Case
- AS in Everyday Practice: The Curbside Call Case
- AS in Everyday Practice: The Prospective Audit and Feedback Cas
- AS in Everyday Practice: The Rapid Diagnostic Dilemma Case
The cases are based on common ID clinical scenarios and highlight specific AS practices in routine clinical care. Each of the 5 cases has formative questions embedded in the case, suggestions for applying concepts in practice, and a “clinical pearls” pocket card for reference. If the resources available, you are encouraged to complete at least 3 AS debriefing activities with faculty at your home or neighboring institution during routine patient care.
Target Audience
Infectious Diseases Professionals and others who desire to learn more about antimicrobial stewardship but are not in a participating fellowship program, no longer in fellowship, or would like to gain more knowledge on the subject.
Learning Objectives
Upon completion of this section, you will be able to:
- Judge when to recommend formal ID consultation or AS intervention
- Recognize the major “infectious diseases syndromes” where antimicrobials are over- and misused in acute care inpatient and outpatient settings, and the stewardship techniques to improve prescribing for these infections
- Identify common process and outcome measures/metrics
- Compare and contrast effective AS techniques in the inpatient vs. outpatient settings
NOTE: Because this curriculum was initially designed specifically for fellows, you may hear repeated reference to "fellows" , "stewards in training", or "fellows/trainees".
AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found
Name | Individual's Role in Activity | Name of Commercial Interest | Nature of Relationship |
---|---|---|---|
Abbo, Lillian | Workgroup member | Pfizer Brazil | Honoraria |
Advani, Sonali | Workgroup member | Nabriva Therapeutics | Advisory/Consultant Role |
Amstrong, Wendy | Workgroup member | None | |
Barsoumian, Alice | Workgroup member | None | |
Beeler, Cole | Workgroup member | None | |
Bystritsky, Rachel | Workgroup member | None | |
Cherabuddi, Kartik | Workgroup member | Gatorade | Start - up Research Fund |
NIH (Medimmune) | Research Grant | ||
Cohen, Seth | Workgroup member | None | |
Hamilton, Keith | Workgroup member | None | |
Ince, Dilek | Workgroup member | Ansun Pharma | Research Grant |
Justo, Julie Ann | Workgroup member | None | |
Logan, Ashleigh | Staff | None | |
Luther, Vera | Workgroup member | None | |
Lynch, John | Workgroup member | Astellas Pharmaceuticals, Juno Therapeutics | Advisory/Consultant Role |
Nori, Priya | Workgroup member | None | |
Ohl, Christopher | Workgroup member | Paratek, Bayer, Cempra Pharmaceuticals | Advisory/Consultant Role |
Patel, Payal | Workgroup member | None | |
Pottinger, Paul | Workgroup member | McGraw Hill, Elsevier | Honoraria |
Schwartz, Brian | Workgroup member | None | |
Spicer, Jennifer | Workgroup member | None | |
Stack, Conor | Workgroup member | None | |
Zhou, Yuan | Workgroup member | None | |
Shnekendorf, Rachel | Staff | None |